Company news

Towa Pharmaceutical Co., Ltd. news in 2026

Towa Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(Change in Disclosure Information) Notice of Change in the Date of Execution of the Share Transfer Concerning the Acquisition of Shares

October 30, 2026

FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)

September 1, 2026

Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)

August 6, 2026

Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment

July 31, 2026

Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

July 10, 2026

Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals

July 3, 2026

Notice of Changes in Officers

June 24, 2026

FY2025 Briefing Script and Q&A Summary of financial results meeting(581K／27P)

June 16, 2026

FY2025 Supplementary Material of Financial Results(1.0M／46P)

May 14, 2026

FY2025 Consolidated Financial Results for the Year Ended March 31, 2026(Based on Japanese GAAP) (224K／22P)

May 14, 2026

FY2025(3rd quarter) Briefing Script and Q&A Summary of financial results meeting(296K／17P)

March 18, 2026

FY2025(3rd quarter) Supplementary Material of Financial Results(701K／24P)

February 13, 2026

FY2025(3rd quarter) Consolidated Financial Results for the Nine Months Ended December 31, 2025(Based on Japanese GAAP) (182K／13P)

February 13, 2026

Decks in 2026